Neuroscience Antibodies and Assays
Neuroscience Antibodies and Assays market is segmented by players, region (country), by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lungs in Vitro Model Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 2D Cell Models 1.2.3 3D Cell Models 1.3 Market by Application 1.3.1 Global Lungs in Vitro Model Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Drug Discovery and Toxicology 1.3.3 3D Model Development 1.3.4 Basic Research 1.3.5 Physiological Research 1.3.6 Stem Cell Research and Regenerative Medicine 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lungs in Vitro Model Market Perspective (2017-2028) 2.2 Lungs in Vitro Model Growth Trends by Region 2.2.1 Lungs in Vitro Model Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Lungs in Vitro Model Historic Market Size by Region (2017-2022) 2.2.3 Lungs in Vitro Model Forecasted Market Size by Region (2023-2028) 2.3 Lungs in Vitro Model Market Dynamics 2.3.1 Lungs in Vitro Model Industry Trends 2.3.2 Lungs in Vitro Model Market Drivers 2.3.3 Lungs in Vitro Model Market Challenges 2.3.4 Lungs in Vitro Model Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lungs in Vitro Model Players by Revenue 3.1.1 Global Top Lungs in Vitro Model Players by Revenue (2017-2022) 3.1.2 Global Lungs in Vitro Model Revenue Market Share by Players (2017-2022) 3.2 Global Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Lungs in Vitro Model Revenue 3.4 Global Lungs in Vitro Model Market Concentration Ratio 3.4.1 Global Lungs in Vitro Model Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Model Revenue in 2021 3.5 Lungs in Vitro Model Key Players Head office and Area Served 3.6 Key Players Lungs in Vitro Model Product Solution and Service 3.7 Date of Enter into Lungs in Vitro Model Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lungs in Vitro Model Breakdown Data by Type 4.1 Global Lungs in Vitro Model Historic Market Size by Type (2017-2022) 4.2 Global Lungs in Vitro Model Forecasted Market Size by Type (2023-2028) 5 Lungs in Vitro Model Breakdown Data by Application 5.1 Global Lungs in Vitro Model Historic Market Size by Application (2017-2022) 5.2 Global Lungs in Vitro Model Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Lungs in Vitro Model Market Size (2017-2028) 6.2 North America Lungs in Vitro Model Market Size by Country (2017-2022) 6.3 North America Lungs in Vitro Model Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Lungs in Vitro Model Market Size (2017-2028) 7.2 Europe Lungs in Vitro Model Market Size by Country (2017-2022) 7.3 Europe Lungs in Vitro Model Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Lungs in Vitro Model Market Size (2017-2028) 8.2 Asia-Pacific Lungs in Vitro Model Market Size by Country (2017-2022) 8.3 Asia-Pacific Lungs in Vitro Model Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Lungs in Vitro Model Market Size (2017-2028) 9.2 Latin America Lungs in Vitro Model Market Size by Country (2017-2022) 9.3 Latin America Lungs in Vitro Model Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lungs in Vitro Model Market Size (2017-2028) 10.2 Middle East & Africa Lungs in Vitro Model Market Size by Country (2017-2022) 10.3 Middle East & Africa Lungs in Vitro Model Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 ATCC 11.1.1 ATCC Company Detail 11.1.2 ATCC Business Overview 11.1.3 ATCC Lungs in Vitro Model Introduction 11.1.4 ATCC Revenue in Lungs in Vitro Model Business (2017-2022) 11.1.5 ATCC Recent Development 11.2 Lonza 11.2.1 Lonza Company Detail 11.2.2 Lonza Business Overview 11.2.3 Lonza Lungs in Vitro Model Introduction 11.2.4 Lonza Revenue in Lungs in Vitro Model Business (2017-2022) 11.2.5 Lonza Recent Development 11.3 Epithelix 11.3.1 Epithelix Company Detail 11.3.2 Epithelix Business Overview 11.3.3 Epithelix Lungs in Vitro Model Introduction 11.3.4 Epithelix Revenue in Lungs in Vitro Model Business (2017-2022) 11.3.5 Epithelix Recent Development 11.4 Mattek 11.4.1 Mattek Company Detail 11.4.2 Mattek Business Overview 11.4.3 Mattek Lungs in Vitro Model Introduction 11.4.4 Mattek Revenue in Lungs in Vitro Model Business (2017-2022) 11.4.5 Mattek Recent Development 11.5 Emulate 11.5.1 Emulate Company Detail 11.5.2 Emulate Business Overview 11.5.3 Emulate Lungs in Vitro Model Introduction 11.5.4 Emulate Revenue in Lungs in Vitro Model Business (2017-2022) 11.5.5 Emulate Recent Development 11.6 Mimetas 11.6.1 Mimetas Company Detail 11.6.2 Mimetas Business Overview 11.6.3 Mimetas Lungs in Vitro Model Introduction 11.6.4 Mimetas Revenue in Lungs in Vitro Model Business (2017-2022) 11.6.5 Mimetas Recent Development 11.7 Tissuse 11.7.1 Tissuse Company Detail 11.7.2 Tissuse Business Overview 11.7.3 Tissuse Lungs in Vitro Model Introduction 11.7.4 Tissuse Revenue in Lungs in Vitro Model Business (2017-2022) 11.7.5 Tissuse Recent Development 11.8 Insphero 11.8.1 Insphero Company Detail 11.8.2 Insphero Business Overview 11.8.3 Insphero Lungs in Vitro Model Introduction 11.8.4 Insphero Revenue in Lungs in Vitro Model Business (2017-2022) 11.8.5 Insphero Recent Development 11.9 Cn Bio 11.9.1 Cn Bio Company Detail 11.9.2 Cn Bio Business Overview 11.9.3 Cn Bio Lungs in Vitro Model Introduction 11.9.4 Cn Bio Revenue in Lungs in Vitro Model Business (2017-2022) 11.9.5 Cn Bio Recent Development 11.10 AlveoliX 11.10.1 AlveoliX Company Detail 11.10.2 AlveoliX Business Overview 11.10.3 AlveoliX Lungs in Vitro Model Introduction 11.10.4 AlveoliX Revenue in Lungs in Vitro Model Business (2017-2022) 11.10.5 AlveoliX Recent Development 11.11 Oncotheis 11.11.1 Oncotheis Company Detail 11.11.2 Oncotheis Business Overview 11.11.3 Oncotheis Lungs in Vitro Model Introduction 11.11.4 Oncotheis Revenue in Lungs in Vitro Model Business (2017-2022) 11.11.5 Oncotheis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Lungs in Vitro Model Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of 2D Cell Models Table 3. Key Players of 3D Cell Models Table 4. Global Lungs in Vitro Model Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Lungs in Vitro Model Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Lungs in Vitro Model Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Lungs in Vitro Model Market Share by Region (2017-2022) Table 8. Global Lungs in Vitro Model Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Lungs in Vitro Model Market Share by Region (2023-2028) Table 10. Lungs in Vitro Model Market Trends Table 11. Lungs in Vitro Model Market Drivers Table 12. Lungs in Vitro Model Market Challenges Table 13. Lungs in Vitro Model Market Restraints Table 14. Global Lungs in Vitro Model Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Lungs in Vitro Model Market Share by Players (2017-2022) Table 16. Global Top Lungs in Vitro Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2021) Table 17. Ranking of Global Top Lungs in Vitro Model Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Lungs in Vitro Model Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Lungs in Vitro Model Product Solution and Service Table 21. Date of Enter into Lungs in Vitro Model Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Lungs in Vitro Model Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Lungs in Vitro Model Revenue Market Share by Type (2017-2022) Table 25. Global Lungs in Vitro Model Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Lungs in Vitro Model Revenue Market Share by Type (2023-2028) Table 27. Global Lungs in Vitro Model Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Lungs in Vitro Model Revenue Market Share by Application (2017-2022) Table 29. Global Lungs in Vitro Model Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Lungs in Vitro Model Revenue Market Share by Application (2023-2028) Table 31. North America Lungs in Vitro Model Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Lungs in Vitro Model Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Lungs in Vitro Model Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Lungs in Vitro Model Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Lungs in Vitro Model Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Lungs in Vitro Model Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Lungs in Vitro Model Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Lungs in Vitro Model Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Lungs in Vitro Model Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Lungs in Vitro Model Market Size by Country (2023-2028) & (US$ Million) Table 41. ATCC Company Detail Table 42. ATCC Business Overview Table 43. ATCC Lungs in Vitro Model Product Table 44. ATCC Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 45. ATCC Recent Development Table 46. Lonza Company Detail Table 47. Lonza Business Overview Table 48. Lonza Lungs in Vitro Model Product Table 49. Lonza Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 50. Lonza Recent Development Table 51. Epithelix Company Detail Table 52. Epithelix Business Overview Table 53. Epithelix Lungs in Vitro Model Product Table 54. Epithelix Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 55. Epithelix Recent Development Table 56. Mattek Company Detail Table 57. Mattek Business Overview Table 58. Mattek Lungs in Vitro Model Product Table 59. Mattek Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 60. Mattek Recent Development Table 61. Emulate Company Detail Table 62. Emulate Business Overview Table 63. Emulate Lungs in Vitro Model Product Table 64. Emulate Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 65. Emulate Recent Development Table 66. Mimetas Company Detail Table 67. Mimetas Business Overview Table 68. Mimetas Lungs in Vitro Model Product Table 69. Mimetas Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 70. Mimetas Recent Development Table 71. Tissuse Company Detail Table 72. Tissuse Business Overview Table 73. Tissuse Lungs in Vitro Model Product Table 74. Tissuse Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 75. Tissuse Recent Development Table 76. Insphero Company Detail Table 77. Insphero Business Overview Table 78. Insphero Lungs in Vitro Model Product Table 79. Insphero Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 80. Insphero Recent Development Table 81. Cn Bio Company Detail Table 82. Cn Bio Business Overview Table 83. Cn Bio Lungs in Vitro Model Product Table 84. Cn Bio Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 85. Cn Bio Recent Development Table 86. AlveoliX Company Detail Table 87. AlveoliX Business Overview Table 88. AlveoliX Lungs in Vitro Model Product Table 89. AlveoliX Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 90. AlveoliX Recent Development Table 91. Oncotheis Company Detail Table 92. Oncotheis Business Overview Table 93. Oncotheis Lungs in Vitro ModelProduct Table 94. Oncotheis Revenue in Lungs in Vitro Model Business (2017-2022) & (US$ Million) Table 95. Oncotheis Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Lungs in Vitro Model Market Share by Type: 2021 VS 2028 Figure 2. 2D Cell Models Features Figure 3. 3D Cell Models Features Figure 4. Global Lungs in Vitro Model Market Share by Application in 2021 & 2028 Figure 5. Drug Discovery and Toxicology Case Studies Figure 6. 3D Model Development Case Studies Figure 7. Basic Research Case Studies Figure 8. Physiological Research Case Studies Figure 9. Stem Cell Research and Regenerative Medicine Case Studies Figure 10. Lungs in Vitro Model Report Years Considered Figure 11. Global Lungs in Vitro Model Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Lungs in Vitro Model Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Lungs in Vitro Model Market Share by Region: 2021 VS 2028 Figure 14. Global Lungs in Vitro Model Market Share by Players in 2021 Figure 15. Global Top Lungs in Vitro Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Lungs in Vitro Model Revenue in 2021 Figure 17. North America Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Lungs in Vitro Model Market Share by Country (2017-2028) Figure 19. United States Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Lungs in Vitro Model Market Share by Country (2017-2028) Figure 23. Germany Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Lungs in Vitro Model Market Share by Region (2017-2028) Figure 31. China Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Lungs in Vitro Model Market Share by Country (2017-2028) Figure 39. Mexico Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Lungs in Vitro Model Market Share by Country (2017-2028) Figure 43. Turkey Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Lungs in Vitro Model Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. ATCC Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 46. Lonza Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 47. Epithelix Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 48. Mattek Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 49. Emulate Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 50. Mimetas Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 51. Tissuse Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 52. Insphero Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 53. Cn Bio Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 54. AlveoliX Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 55. Oncotheis Revenue Growth Rate in Lungs in Vitro Model Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed
ATCC Lonza Epithelix Mattek Emulate Mimetas Tissuse Insphero Cn Bio AlveoliX Oncotheis
Neuroscience Antibodies and Assays market is segmented by players, region (country), by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Revenue Management Software market is segmented by players, region (country), by Type and by Appl ... Read More